Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Almirall, S.A.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
mild to moderate stable chronic plaque-type psoriasis with at least two symmetrical lesions with a treatment area of 20 - 300 cm² and a TSS of ≥ 6;
* female volunteers of childbearing potential\* must agree to use appropriate and reliable methods of contraception
* written informed consent obtained.
You may not be if
severe forms of psoriasis or forms of psoriasis other than chronic plaque psoriasis,
treatment with any locally acting medications which might counter or influence the trial aim within 2 weeks preceding the treatment phase of the trial and during the trial;
treatment with any systemic medications which might counter or influence the trial aim or phototherapy/PUVA within 4 weeks preceding the treatment phase of the trial and during the trial;
treatment with vitamin A supplements;
treatment with any biologics within 3 months preceding the treatment phase of the trial and during the trial, or in the case of ustekinumab, within 6 months;
treatment with any immunosuppressive medication within 6 months preceding the treatment phase of the trial and during the trial;
known allergic reactions, irritations or hypersensitivity to the active ingredients
contraindications according to summary of product characteristics (SmPC) of the active comparator: - pregnancy or nursing;
